{
    "clinical_study": {
        "@rank": "87393", 
        "acronym": "TROPICAL-ACS", 
        "arm_group": [
            {
                "arm_group_label": "Prasugrel", 
                "arm_group_type": "Active Comparator", 
                "description": "Prasugrel 5 mg or 10mg daily for 12 months."
            }, 
            {
                "arm_group_label": "Prasugrel/Clopidogrel", 
                "arm_group_type": "Experimental", 
                "description": "Day 0 - 7 Prasugrel 5 or 10mg Day 8 - 14 Clopidogrel 75mg q/d. On Day 14 platelet function testing Patients with HPR will be switched to Prasugrel the others will remain on Clopidogrel for 11 1/2 months"
            }
        ], 
        "brief_summary": {
            "textblock": "This study investigates whether a platelet function testing guided approach with a\n      short-term (1 week) prasugrel treatment and a switch over to clopidogrel treatment in\n      adequate responders to clopidogrel is non-inferior regarding the combined incidence of\n      bleeding and thrombotic complications to a 12 month standard treatment with prasugrel in\n      acute coronary syndrome (ACS) patients treated with percutaneous coronary intervention\n      (PCI)."
        }, 
        "brief_title": "Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Coronary Syndrome", 
        "condition_browse": {
            "mesh_term": "Acute Coronary Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Patients suffering of heart attack have highly activated blood platelets. During and after\n      invasive treatment of blocked coronary vessels (percutaneous coronary intervention = PCI) a\n      potent platelet inhibition is needed to reduce the risk of thrombotic complications which is\n      particularly high within the first week after PCI. On the other hand, the use of potent\n      platelet inhibitors such as prasugrel is associated with higher bleeding risk particularly\n      when used at long-term.  A combination of a potent antiplatelet drug (prasugrel) within the\n      first week with a less potent antiplatelet drug (clopidogrel) thereafter might lead to a\n      higher net clinical benefit - means less bleeding and thrombotic complications. This\n      hypothesis is being investigated in the current trial."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with Troponin positive ACS\n\n          -  Successful PCI (defined as a post PCI diameter stenosis <20% and TIMI flow \u22652)\n\n          -  A planned treatment of Prasugrel for 12 months after the procedure\n\n          -  written informed consent\n\n        Exclusion Criteria:\n\n          -  Age <18 years and >80 years\n\n          -  Subjects with known contraindications to Clopidogrel treatment, which are\n             hypersensitivity to the drug substance or any component of the product and active\n             pathological bleeding such as peptic ulcer or intracranial hemorrhage\n\n          -  Subjects with known contraindications to Prasugrel treatment, which are\n             hypersensitivity to the drug substance or any component of the product, active\n             pathological bleeding such as peptic ulcer or intracranial hemorrhage and a history\n             of prior transient ischemic attack (TIA) or stroke\n\n          -  Cardiogenic shock\n\n          -  Subjects requiring concomitant treatment with an anticoagulant agent (Vitamin-K\n             antagonists or novel oral anticoagulants such as Rivaroxaban, Dabigatran or Apixaban)\n\n          -  Indication for major surgery (per decision of the treating physician) for the planned\n             duration of the study\n\n          -  Simultaneous participation in another clinical trial or participation in any clinical\n             trial involving administration of an investigational medicinal product within 30 days\n             prior to clinical trial beginning\n\n          -  Known or persistent abuse of medication, drugs or alcohol\n\n          -  Current or planned pregnancy or nursing women, women 90 days after childbirth.\n             Females of childbearing potential, who do not use and are not willing to use\n             medically reliable methods of contraception for the entire study duration (such as\n             oral, injectable, or implantable contraceptives, or intrauterine contraceptive\n             devices) unless they are surgically sterilized / hysterectomized or there are any\n             other criteria considered sufficiently reliable by the investigator in individual\n             cases\n\n          -  Evidence of significant active neuropsychiatric disease, in the investigator's\n             opinion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01959451", 
            "org_study_id": "MucT001-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Prasugrel", 
                "description": "see Arm description", 
                "intervention_name": "Prasugrel", 
                "intervention_type": "Drug", 
                "other_name": "Efient"
            }, 
            {
                "arm_group_label": "Prasugrel/Clopidogrel", 
                "description": "see arm description", 
                "intervention_name": "Clopidogrel", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Iscover", 
                    "Plavix"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clopidogrel", 
                "Prasugrel"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prasugrel", 
            "Clopidogrel"
        ], 
        "lastchanged_date": "March 28, 2014", 
        "location": [
            {
                "contact": {
                    "email": "franz-josef.neumann@universitaets-herzzentrum.de", 
                    "last_name": "Franz-Josef Neumann, MD"
                }, 
                "contact_backup": {
                    "email": "Dietmar.Trenk@universitaets-herzzentrum.de", 
                    "last_name": "Dietmar Trenk, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bad Krozingen", 
                        "country": "Germany", 
                        "zip": "79189"
                    }, 
                    "name": "Heart Center Bad Krozingen"
                }, 
                "investigator": [
                    {
                        "last_name": "Franz-Josef Neumann, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Dieter Trenk", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "a.muegge@klinikum-bochum.de", 
                    "last_name": "Andreas M\u00fcgge, MD"
                }, 
                "contact_backup": {
                    "email": "k.kara@klinikum-bochum.de", 
                    "last_name": "Kara Kaffer, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "zip": "44791"
                    }, 
                    "name": "St. Josef Hospital im Katholischen Klinikum Bochum Department of Cardiology"
                }, 
                "investigator": [
                    {
                        "last_name": "Andreas M\u00fcgge, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Kara Kaffer, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jacobshagen@med.uni-goettingen.de", 
                    "last_name": "Claudius Jacobshagen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Goettingen", 
                        "country": "Germany", 
                        "zip": "37075"
                    }, 
                    "name": "Heart Center at the University Medical Center Goettingen"
                }, 
                "investigator": {
                    "last_name": "Claudius Jacobshagen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Tommaso.Gori@unimedizin-mainz.de", 
                    "last_name": "Tomasso Gori, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany", 
                        "zip": "55131"
                    }, 
                    "name": "University Hospital Mainz, Department of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Tommaso Gori, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dirk.sibbing@med.uni-muenchen.de", 
                    "last_name": "Dirk Sibbing, MD", 
                    "phone": "+49 89 5160", 
                    "phone_ext": "2266"
                }, 
                "contact_backup": {
                    "email": "Monika.Baylacher@med.uni-muenchen.de", 
                    "last_name": "Monika Baylacher", 
                    "phone": "+49 89 5160", 
                    "phone_ext": "7670"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80336"
                    }, 
                    "name": "Munich University Clinic, Campus Innenstadt"
                }, 
                "investigator": {
                    "last_name": "Dirk Sibbing, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "julinda.mehilli@med.uni-muenchen.de", 
                    "last_name": "Julinda Mehilli, MD", 
                    "phone": "+49 89 7095", 
                    "phone_ext": "3053"
                }, 
                "contact_backup": {
                    "email": "martina.schulz@med.uni-muenchen.de", 
                    "last_name": "Martina Schulz", 
                    "phone": "+49 89 7095", 
                    "phone_ext": "3064"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "81337"
                    }, 
                    "name": "Munich University Clinic, Campus Grosshadern"
                }, 
                "investigator": [
                    {
                        "last_name": "Julinda Mehilli, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Martin Orban, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Johannes.Rieber@klinikum-muenchen.de", 
                    "last_name": "Johannes Rieber, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "81925"
                    }, 
                    "name": "Klinikum Bogenhausen"
                }, 
                "investigator": {
                    "last_name": "Johannes Rieber, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tobias.geisler@med.uni-tuebingen.de", 
                    "last_name": "Tobias Geisler, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tuebingen", 
                        "country": "Germany", 
                        "zip": "72076"
                    }, 
                    "name": "University Clinic of Tuebingen, Department of Cardiology and Cardiovascular Medicine"
                }, 
                "investigator": {
                    "last_name": "Tobias Geisler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daniel_aradi@yahoo.com", 
                    "last_name": "Daniel Aradi, MD", 
                    "phone": "+36302355639"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "8230"
                    }, 
                    "name": "Heart Center Balatonf\u00fcred"
                }, 
                "investigator": {
                    "last_name": "Daniel Aradi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Hungary"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Platelet Function Guided Prasugrel Therapy in ACS Patients Undergoing PCI", 
        "other_outcome": {
            "measure": "economic impact of a platelet function testing guided tailored treatment for ACS patients", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "overall_contact": {
            "email": "dirk.sibbing@med.uni-muenchen.de", 
            "last_name": "Dirk Sibbing, MD", 
            "phone": "+49 89 5160", 
            "phone_ext": "2266"
        }, 
        "overall_contact_backup": {
            "email": "julinda.mehilli@med.uni-muenchen.de", 
            "last_name": "Julinda Mehilli, MD", 
            "phone": "+49 89 7095", 
            "phone_ext": "3053"
        }, 
        "overall_official": [
            {
                "affiliation": "Munich University Clinic, Campus Innenstadt", 
                "last_name": "Dirk Sibbing, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Munich University Clinic, Campus Grosshadern", 
                "last_name": "Julinda Mehilli, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Munich University Clinic, Campus Grosshadern and Innenstadt", 
                "last_name": "Steffen Massberg, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Composite of death from cardiovascular cause, myocardial infarction, stroke and bleeding grade \u2265 2 defined according to BARC criteria", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01959451"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "bleeding events BARC class \u22652", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "stent thrombosis", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "all-cause death", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Klinikum der Universitaet Muenchen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Klinikum der Universitaet Muenchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}